These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7261412)

  • 1. Familial hypercholesterolaemia and primary hypothyroidism: coexistence of both disorders in a young woman with severe hypercholesterolaemia.
    Illingworth DR; McClung MR; Connor WE; Alaupovic P
    Clin Endocrinol (Oxf); 1981 Feb; 14(2):145-52. PubMed ID: 7261412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of isoapolipoprotein-E3 deficiency with heterozygous familial hypercholesterolaemia: implications for lipoprotein physiology.
    Hazzard WR; Miller N; Albers JJ; Warnick GR; Baron P; Lewis B
    Lancet; 1981 Feb; 1(8215):298-301. PubMed ID: 6109941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.
    Real JT; Chaves FJ; Martínez-Usó I; García-García AB; Ascaso JF; Carmena R
    Eur Heart J; 2001 Mar; 22(6):465-71. PubMed ID: 11237541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of coronary flow haemodynamics in homozygous familial hypercholesterolaemic adolescents with aortic supravalvular stenosis.
    Wang Z; Yang Y; Li Z; Zhang X; Lin J; Wang L
    Cardiol Young; 2013 Apr; 23(2):219-24. PubMed ID: 22647298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Articular manifestations of familial hypercholesterolaemia.
    Mathon G; Gagné C; Brun D; Lupien PJ; Moorjani S
    Ann Rheum Dis; 1985 Sep; 44(9):599-602. PubMed ID: 4037885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.
    Santos RD; Gidding SS; Hegele RA; Cuchel MA; Barter PJ; Watts GF; Baum SJ; Catapano AL; Chapman MJ; Defesche JC; Folco E; Freiberger T; Genest J; Hovingh GK; Harada-Shiba M; Humphries SE; Jackson AS; Mata P; Moriarty PM; Raal FJ; Al-Rasadi K; Ray KK; Reiner Z; Sijbrands EJ; Yamashita S;
    Lancet Diabetes Endocrinol; 2016 Oct; 4(10):850-61. PubMed ID: 27246162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of probucol on plasma lipoproteins in polygenic and familial hypercholesterolaemia.
    Cortese C; Marenah CB; Miller NE; Lewis B
    Atherosclerosis; 1982 Sep; 44(3):319-25. PubMed ID: 7150396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothyroidism presenting as hypercholesterolaemia and simvastatin-induced myositis.
    Hung YT; Yeung VT
    Hong Kong Med J; 2000 Dec; 6(4):423-4. PubMed ID: 11177166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The magnitude of the hypercholesterolemia of hypothyroidism is associated with variation in the low density lipoprotein receptor gene.
    Wiseman SA; Powell JT; Humphries SE; Press M
    J Clin Endocrinol Metab; 1993 Jul; 77(1):108-12. PubMed ID: 8100826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between treatments of severe forms of familial hypercholesterolemia by total plasma exchange and selective removal of low density lipoproteins (LDLapheresis)].
    Dairou F; Rottembourg J; de Gennes JL; Assogba U; Bruckert E; Jacobs C; Truffert J
    Presse Med; 1988 Oct; 17(33):1679-82. PubMed ID: 2973030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anacetrapib as lipid-modifying therapy in patients with heterozygous familial hypercholesterolaemia (REALIZE): a randomised, double-blind, placebo-controlled, phase 3 study.
    Kastelein JJ; Besseling J; Shah S; Bergeron J; Langslet G; Hovingh GK; Al-Saady N; Koeijvoets M; Hunter J; Johnson-Levonas AO; Fable J; Sapre A; Mitchel Y
    Lancet; 2015 May; 385(9983):2153-61. PubMed ID: 25743173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arthritis in a patient with homozygous familial hypercholesterolemia.
    Genel F; Atlihan F; Bak M; Targan S; Dizdarer C
    Acta Paediatr Jpn; 1997 Jun; 39(3):362-3. PubMed ID: 9241902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis.
    Haba T; Sakai Y; Koizumi J; Miyamoto S; Mabuchi H; Takeda R
    Metabolism; 1983 Dec; 32(12):1129-32. PubMed ID: 6316072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pinpoint skin lesions in a familial hypercholesterolaemia homozygote.
    Milionis HJ; Miltiadous GA; Cariolou M; Elisaf MS
    Acta Paediatr; 2003 Sep; 92(9):1109-10. PubMed ID: 14599079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercholesterolaemia presenting in a patient with familial defective apolipoprotein B-100 and hypothyroidism.
    Wenham PR; Giles PD; Ashby JP
    Ann Clin Biochem; 1995 Mar; 32 ( Pt 2)():221-5. PubMed ID: 7785956
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of familial hypercholesterolaemia in children and adolescents in the last three decades.
    Elis A; Zhou R; Stein EA
    Cardiol Young; 2014 Jun; 24(3):437-41. PubMed ID: 23659280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe familial hypercholesterolaemia: current and future management.
    Farnier M; Bruckert E
    Arch Cardiovasc Dis; 2012 Dec; 105(12):656-65. PubMed ID: 23199621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study.
    Langsted A; Kamstrup PR; Benn M; Tybjærg-Hansen A; Nordestgaard BG
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):577-87. PubMed ID: 27185354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.